Original Research

Cost-Effectiveness Analysis Of EGFR Mutation Testing And Afatinib Versus Gemcitabine-Cisplatin As First-Line Therapy For Advanced Non-Small-Cell Lung Cancer In China

You R, Liu J, Wu DBC, Qian X, Lyu B, Zhang Y, Luo N

Cancer Management and Research 2019, 11:10239-10248

Published Date: 5 December 2019